Printer Friendly

Articles from M2 Pharma (November 18, 2019)

1-17 out of 17 article(s)
Title Author Type Words
3SBio signs collaboration agreement with Verseau Therapeutics for VTX-0811. 206
BIOCORP partners with VITROBIO PHARMA to produce first drug treatment against allergy related to pollution. 247
BIONIK Laboratories announces lower comprehensive loss of USD3.38m in Q2 fiscal 2020. Financial report 197
Bristol-Myers Squibb Company extends exchange offer expiration date of Celgene Corporation notes. 203
Cantargia's pre-IND meeting with US FDA results in advancement of development of antibody CAN04. 360
Cerveau Technologies Starts Japanese Phase I Study. 185
Continental Who's Who honours James J Roberds, PharmD. 128
EpicentRx raises USD35m in Series D financing. 159
Exicure and Allergan Ink Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders. 212
Footit Medical Supply elects Natalia Sinigur as VP. 110
Novartis wins FDA approval of Adakveo to reduce frequency of pain crises in sickle cell disease patients. 331
Sinovac Biotech Ltd posts net income of USD6.3m for Q3 2019. Financial report 182
The FDA authorises marketing of duodenoscopes with disposable elevator component for use with endoscopic devices. 220
US FDA approves first contact lens indicated to slow the progression of myopia in children. 268
US FDA grants approval to Shionogi's Fetroja. 142
US FDA grants AstraZeneca and Merck New Drug Application and priority review for Selumetinib. 230
Xbrane Biopharma swings to loss in Q3 2019. Financial report 165

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |